About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Renal Denervation in Patients After Acute Coronary Syndrome

NCT01901549·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Evgeny Pokushalov, MD, PhD
CONTACT
+79139254858 e.pokushalov@gmail.com

Lead

Meshalkin Research Institute of Pathology of Circulation

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

acute Q negative myocardium infarction (during first 14 days)
non stable angina
significant stenosis
BP \> 140/90 torr. during more than 1 year

You may not be if

absence of arterial hypertension
Thrombolysis during previous 24 hours
indications for CABG

The record

StatusUnknown

PhasePhase 2

Taking part80

StartedJun 2013

UpdatedSep 23, 2015

Conditions

Acute Coronary Syndrome Arterial Hypertension

Where1

State Research Institute of Circulation Pathology
Novosibirsk, Russia

Clareo Health | Renal Denervation in Patients After Acute Coronary Syndrome